These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30098500)

  • 1. Intravenous thrombolysis in stroke patients taking novel oral anticoagulants: experience with the low-dose 0.6 mg/kg of recombinant tissue-type plasminogen activator. Case reports.
    Plastino M; Bosco D; Giofrè L; Cristiano D; Galati F; Postorino P; Consoli A; Fava A; Consoli D
    J Neurol Sci; 2018 Oct; 393():24-26. PubMed ID: 30098500
    [No Abstract]   [Full Text] [Related]  

  • 2. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab.
    Berrouschot J; Stoll A; Hogh T; Eschenfelder CC
    Stroke; 2016 Jul; 47(7):1936-8. PubMed ID: 27301937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous recombinant tissue plasminogen activator for acute stroke in Poland: an analysis based on the Safe Implementation of Thrombolysis in Stroke (SITS) Registry.
    Kobayashi A; Czlonkowska A; Ahmed N; Romanowicz S; Glonek M; Nyka WM; Opala G; Wahlgren N;
    Acta Neurol Scand; 2010 Oct; 122(4):229-36. PubMed ID: 19919643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran.
    De Smedt A; De Raedt S; Nieboer K; De Keyser J; Brouns R
    Cerebrovasc Dis; 2010; 30(5):533-4. PubMed ID: 20881383
    [No Abstract]   [Full Text] [Related]  

  • 6. [Management of acute ischemic stroke].
    Minematsu K
    No To Shinkei; 2004 Nov; 56(11):921-6. PubMed ID: 15678948
    [No Abstract]   [Full Text] [Related]  

  • 7. Dilemma of indication for thrombolysis in a patient with acute ischemic stroke treated with a novel oral anticoagulant.
    Folyovich A; Varga V; Béres-Molnár KA; Vadasdi K; Bereczki D
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):580-2. PubMed ID: 23721623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of Intravenous Thrombolysis among Stroke Patients Taking New Oral Anticoagulants--Case Series and Systematic Review of Reported Cases.
    Shahjouei S; Tsivgoulis G; Bavarsad Shahripour R; Jones GM; Alexandrov AV; Zand R
    J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2685-93. PubMed ID: 26542821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolysis with tissue plasminogen activator: protocol violation is not an option.
    Kumar S
    Neurol India; 2007; 55(2):174; author reply 174-5. PubMed ID: 17558129
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants.
    Touzé E; Gruel Y; Gouin-Thibault I; De Maistre E; Susen S; Sie P; Derex L
    Eur J Neurol; 2018 May; 25(5):747-e52. PubMed ID: 29360254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of severity of stroke and aphasia recovery early after intravenous recombinant tissue plasminogen activator thrombolysis.
    Kremer C; Kappelin J; Perren F
    J Clin Neurosci; 2014 Oct; 21(10):1828-30. PubMed ID: 24852905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatment.
    Diener HC; Foerch C; Riess H; Röther J; Schroth G; Weber R
    Lancet Neurol; 2013 Jul; 12(7):677-88. PubMed ID: 23726849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
    Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
    J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Tissue Plasminogen Activator for a Patient with Stroke After Stanford Type A Aortic Dissection Treatment.
    Matsuzono K; Suzuki M; Arai N; Kim Y; Ozawa T; Mashiko T; Shimazaki H; Koide R; Fujimoto S
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):e132-e134. PubMed ID: 29525082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Neurological Deterioration During Alteplase Infusion for Acute Ischemic Stroke: An Uncommon Complication of Intravenous Thrombolysis.
    Safouris A; Kargiotis O; Magoufis G; Katsanos AH; Stamboulis E; Tsivgoulis G
    Neurologist; 2017 May; 22(3):90-91. PubMed ID: 28471898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior vs. anterior circulation infarction: demography, outcomes, and frequency of hemorrhage after thrombolysis.
    Dorňák T; Král M; Hazlinger M; Herzig R; Veverka T; Buřval S; Šaňák D; Zapletalová J; Antalíková K; Kaňovský P
    Int J Stroke; 2015 Dec; 10(8):1224-8. PubMed ID: 26310390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [First case of thrombolysis with non-immunogenic staphylokinase in a patient with ischemic stroke receiving dabigatran etexilate followed by thrombectomy].
    Ramazanov GR; Kokov LS; Shamalov NA; Kovaleva EA; Klychnikova EV; Akhmatkhanova LK; Cheboksarov DV; Khamidova LT; Muslimov RS; Rybalko NV; Petrikov SS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(6):145-151. PubMed ID: 35758961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic stroke on optimal anticoagulation with novel-oral anticoagulants compared with warfarin.
    Kim BJ; Kang HG; Lee DH; Kang DW; Kim JS; Kwon SU
    Int J Stroke; 2015 Aug; 10(6):E68. PubMed ID: 26202718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.